Rigel Pharmaceuticals (RIGL +4.5%) is up on the day after JP Morgan initiates coverage with an...

|About: Rigel Pharmaceuticals, Inc. (RIGL)|By:, SA News Editor

Rigel Pharmaceuticals (RIGL +4.5%) is up on the day after JP Morgan initiates coverage with an overweight. The firm says Rigel's rheumatoid arthritis Fostamatinib shows a lot of promise and the stock will likely gaing in anticipation of positive results.